Author

Saverio Altieri

University of PaviaORCID 0000-0002-1376-3686Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Agata Jakóbik‐KoloniD· 1 shared Alessandro Somenzi· 1 shared Barbara NawrotiD· 1 shared Damian KaniowskiiD· 1 shared Dongfang WangiD· 1 shared Elaine Y. KangiD· 1 shared Jeremy HalliD· 1 shared Justyna SuwaraiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Agata Jakóbik‐KolonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

EGFR-targeted antisense oligonucleotides modified with boron clusters offer an innovative approach to cancer chemo-radiotherapy

Damian Kaniowski, Katarzyna Ebenryter‐Olbińska, Justyna Suwara, Katarzyna Kulik, Jeremy Hall, Dongfang Wang, Elaine Y. Kang, Rafał Dolot, Alessandro Somenzi, Agata Jakóbik‐Kolon, Nicoletta Protti, Saverio Altieri, Marcin Kortylewski, Barbara Nawrot

This paper demonstrates that B-ASOLNA-CHOL, a boron cluster-conjugated antisense oligonucleotide, enhances cancer cell uptake and cytotoxicity when combined with radiotherapy, reducing tumor size in xenograft models.

bioRxiv · Aug 7, 2025 · PreprintBiochemistry